FI58495C - Analogifoerfarande foer framstaellning av terapeutiskt aktiv 1-(3-(4-m-klorfenyl-1-piperazinyl)-propyl)-3,4-dietyl- 2-1,2,4-triazolin-5-on och farmaceutiskt godtagbara salter daerav - Google Patents

Analogifoerfarande foer framstaellning av terapeutiskt aktiv 1-(3-(4-m-klorfenyl-1-piperazinyl)-propyl)-3,4-dietyl- 2-1,2,4-triazolin-5-on och farmaceutiskt godtagbara salter daerav Download PDF

Info

Publication number
FI58495C
FI58495C FI3188/73A FI318873A FI58495C FI 58495 C FI58495 C FI 58495C FI 3188/73 A FI3188/73 A FI 3188/73A FI 318873 A FI318873 A FI 318873A FI 58495 C FI58495 C FI 58495C
Authority
FI
Finland
Prior art keywords
triazolin
diethyl
treated
therapeutic activities
chloro
Prior art date
Application number
FI3188/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI58495B (fi
Inventor
Giuseppe Palazzo
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of FI58495B publication Critical patent/FI58495B/fi
Application granted granted Critical
Publication of FI58495C publication Critical patent/FI58495C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI3188/73A 1972-10-16 1973-10-15 Analogifoerfarande foer framstaellning av terapeutiskt aktiv 1-(3-(4-m-klorfenyl-1-piperazinyl)-propyl)-3,4-dietyl- 2-1,2,4-triazolin-5-on och farmaceutiskt godtagbara salter daerav FI58495C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT53380/72A IT1052119B (it) 1972-10-16 1972-10-16 Derivati del triazolinone e procedimento per la loro preparazione
IT5338072 1972-10-16

Publications (2)

Publication Number Publication Date
FI58495B FI58495B (fi) 1980-10-31
FI58495C true FI58495C (fi) 1981-02-10

Family

ID=11282276

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3188/73A FI58495C (fi) 1972-10-16 1973-10-15 Analogifoerfarande foer framstaellning av terapeutiskt aktiv 1-(3-(4-m-klorfenyl-1-piperazinyl)-propyl)-3,4-dietyl- 2-1,2,4-triazolin-5-on och farmaceutiskt godtagbara salter daerav

Country Status (19)

Country Link
US (1) US3857845A (US08124317-20120228-C00060.png)
JP (1) JPS5550948B2 (US08124317-20120228-C00060.png)
AR (1) AR204086A1 (US08124317-20120228-C00060.png)
AT (1) AT336021B (US08124317-20120228-C00060.png)
BE (1) BE806146A (US08124317-20120228-C00060.png)
CA (1) CA1013746A (US08124317-20120228-C00060.png)
CH (1) CH589643A5 (US08124317-20120228-C00060.png)
DE (1) DE2351739C3 (US08124317-20120228-C00060.png)
DK (1) DK141750B (US08124317-20120228-C00060.png)
ES (1) ES419687A1 (US08124317-20120228-C00060.png)
FI (1) FI58495C (US08124317-20120228-C00060.png)
FR (1) FR2202702B1 (US08124317-20120228-C00060.png)
GB (1) GB1438337A (US08124317-20120228-C00060.png)
IT (1) IT1052119B (US08124317-20120228-C00060.png)
KE (1) KE2823A (US08124317-20120228-C00060.png)
NL (1) NL184782C (US08124317-20120228-C00060.png)
NO (1) NO138565C (US08124317-20120228-C00060.png)
SE (1) SE390819B (US08124317-20120228-C00060.png)
YU (1) YU39914B (US08124317-20120228-C00060.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1047702B (it) * 1975-07-24 1980-10-20 Acraf Nuova sintesi degli psicofarmaci denominati trazodone ed eteroperidone
US4162318A (en) * 1976-05-05 1979-07-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
IT1073639B (it) * 1976-05-05 1985-04-17 Acraf Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
US4465683A (en) * 1979-09-14 1984-08-14 Mead Johnson & Company Anti-psychotic agents
US4254124A (en) * 1979-09-24 1981-03-03 Mead Johnson & Company Antidepressant agent
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US4931445A (en) * 1988-10-06 1990-06-05 Irwin Goldstein Agents for treatment of male impotence
US5229406A (en) * 1990-09-19 1993-07-20 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5140036A (en) * 1990-09-19 1992-08-18 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5087634A (en) * 1990-10-31 1992-02-11 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5238952A (en) * 1990-10-31 1993-08-24 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Also Published As

Publication number Publication date
DK141750C (US08124317-20120228-C00060.png) 1980-11-03
ATA871173A (de) 1976-08-15
AT336021B (de) 1977-04-12
DE2351739C3 (de) 1980-09-04
NL184782C (nl) 1989-11-01
FI58495B (fi) 1980-10-31
NL7314204A (US08124317-20120228-C00060.png) 1974-04-18
AR204086A1 (es) 1975-11-20
DE2351739B2 (de) 1980-01-10
SE390819B (sv) 1977-01-24
IT1052119B (it) 1981-06-20
BE806146A (fr) 1974-02-15
NO138565C (no) 1978-09-27
YU263473A (en) 1983-02-28
JPS4993381A (US08124317-20120228-C00060.png) 1974-09-05
US3857845A (en) 1974-12-31
NL184782B (nl) 1989-06-01
DK141750B (da) 1980-06-09
YU39914B (en) 1985-06-30
CA1013746A (en) 1977-07-12
JPS5550948B2 (US08124317-20120228-C00060.png) 1980-12-20
FR2202702A1 (US08124317-20120228-C00060.png) 1974-05-10
NO138565B (no) 1978-06-19
ES419687A1 (es) 1976-10-16
GB1438337A (US08124317-20120228-C00060.png) 1976-06-03
KE2823A (en) 1978-03-31
FR2202702B1 (US08124317-20120228-C00060.png) 1976-07-02
DE2351739A1 (de) 1974-04-18
CH589643A5 (US08124317-20120228-C00060.png) 1977-07-15

Similar Documents

Publication Publication Date Title
FI58495C (fi) Analogifoerfarande foer framstaellning av terapeutiskt aktiv 1-(3-(4-m-klorfenyl-1-piperazinyl)-propyl)-3,4-dietyl- 2-1,2,4-triazolin-5-on och farmaceutiskt godtagbara salter daerav
FI70709C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-substituerade imidazolderivat
NO155805B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
FI92053C (fi) Analogiamenetelmä uuden lääkkeen valmistamiseksi
DK167973B1 (da) Indolcarboxamidforbindelser, deres fremstilling samt laegemidler med indhold deraf
US4064245A (en) N-Phenoxyphenyl-piperazines
IE45051B1 (en) 2-substituted-4-amino-6,7-dimethoxy-quinazolines
US5171752A (en) Benzhydryl derivatives having calmodulin inhibitor properties
HU182070B (en) Process for producing phenyl-piperazine derivatives
US3989722A (en) 1-Aminomethyl-2,2-diaryl-cyclopropane carboxamides
EP0053017B1 (en) Amide derivatives
FI85138B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-fenylpropylindolderivat.
IE921319A1 (en) 2-aminopyrimidine-4-carboxamide derivatives, their¹preparation and their application in therapy
IE43222B1 (en) Piperazine derivatives
IE52345B1 (en) Alkanolamine derivatives
NZ206833A (en) Bicyclo(4,2,0)1,3,5-octatrienes
US4479952A (en) Monosubstituted piperazines
US4438121A (en) Isoquinoline amidoxime derivatives
DK169328B1 (da) Indolcarboxamidderivater, deres fremstilling samt farmaceutiske præparater med indhold deraf
DK170043B1 (da) 5-phenyl-1,4,5,6-tetrahydropyrimidinderivater, fremgangsmåde til fremstilling heraf, farmaceutisk middel indeholdende disse samt anvendelse af derivaterne til fremstilling af et farmaceutisk middel
FI60863B (fi) Foerfarande foer framstaellning av nya bentshydryloxialkylaminderivat med foerlaengd antihistamineffekt
JPS584026B2 (ja) ピラジンユウドウタイ オヨビ セイホウ
PL100615B1 (pl) Sposob wytwarzania nowych eterowych pochodnych oksymu
SU1736337A3 (ru) Способ получени [ @ -(трет-бутиламинометил)-3,4-дихлорбензил]-тиоацетамида или его солей
FI69074C (fi) Foerfarande foer framstaellning av som psykotropiskt medel anvaendbar karbazolderivat